Antidepressant-like or anxiolytic-like actions of topiramate alone or co-administered with intra-lateral septal infusions of neuropeptide Y in male Wistar rats

Peptides

Volumn 31, Issue 6, 2010, Pages 1184-1189

  Molina Hernández, Miguel ^a   Téllez Alcántara, N Patricia ^a   Olivera Lopez, Jorge I ^b,c   Jaramillo, M Teresa ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Antidepressant like; Anxiolytic like; DRL 72 s; Elevated plus maze; Lateral Septum; Neuropeptide Y; Topiramate

Indexed keywords

DESIPRAMINE; MIDAZOLAM; NEUROPEPTIDE Y; TOPIRAMATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INFUSION; DRUG POTENTIATION; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MENTAL TASK; NONHUMAN; PRIORITY JOURNAL; RAT; RESPONSE TIME; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DESIPRAMINE; EXPLORATORY BEHAVIOR; FRUCTOSE; MALE; MAZE LEARNING; MIDAZOLAM; NEUROPEPTIDE Y; RATS; RATS, WISTAR; REINFORCEMENT SCHEDULE; SEPTAL NUCLEI;

RATTUS NORVEGICUS;

EID: 77952111993     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.012     Document Type: Article

References (41)

1. Berlant J., and van Kammen D.P. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 63 (2002) 15-20
2. Britton K.T., Southerland S., Uden E., Kirby D., Rivier J., and Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology 132 (1997) 6-13
3. Contreras C.M., Marván M.L., Alcalá V., and Guzmán M.A. Chronic clomipramine increase firing rate in lateral septum nuclei of the rat. Physiol Behav 48 (1990) 551-554
4. Contreras C.M., Chacon L., Rodríguez F., Bernal B., Gutierrez A., and Savedra M. Spontaneous firing rate of lateral septal neurons decreases after forced swimming test in Wistar rat. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 343-348
5. Delini-Stula A., Mikkelsen H., and Angst J. Therapeutic efficacy of antidepressants in agitated anxious depression -a meta analysis of moclobemide studies. J Affect Disord 35 (1995) 21-30
6. Echevarria D.J., Hernandez A., Diogenes A., and Morilak D.A. Administration of the galanin antagonist M40 into lateral septum attenuates shock probe defensive burying behavior in rats. Neuropeptides 39 (2005) 445-451
7. Farook J., Lewis B., Littleton J., and Barron S. Topiramate attenuates the stress-induced increase in alcohol consumption and preference in male C57BL/6J mice. Physiol Behav 96 (2009) 189-193
8. Goyal S., Kokare D., Chopde C., and Subhedar N. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats. Pharmacol Biochem Behav 85 (2006) 369-377
9. Handley S.L., and McBlane J.W. An assessment of the elevated X maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Methods 29 (1993) 129-135
10. Hargreaves G., and McGregor I. Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcoholism: Clin Exp Res 31 (2007) 1900-1907
11. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., et al. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8 (1993) 357-363
12. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
13. Holmes A., Heilig M., Rupniak N., Steckler T., and Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24 (2003) 580-588
14. Jackson A., Koek W., and Colpaert F.C. Can the DRL-72 s paradigm selectively reveal antidepressant drug activity?. Psychopharmacology 117 (1995) 154-161
15. Kask A., Harro J., Von Horsten S., Redrobe J.P., Dumont Y., and Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26 (2002) 259-283
16. Keskinbora K., and Aydinli I. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Clin Neurol Neurosurg 110 (2008) 979-984
17. Khan S., and Liberzon I. Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychophrmacology 172 (2004) 225-229
18. Kokare D., Dandekar M., Chopde C., and Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Res 1043 (2005) 107-114
19. Kostowski W., Dyr W., Krzascik P., Jarbe T., and Archer T. 5-hydroxytryptamine-1 A receptor agonists in animal models of depression and anxiety. Pharmacol Toxicol 71 (1992) 24-30
20. Mathé A., Husum H., El Khoury A., Jiménez-Vasquez P., Gruber S., Wörtwein G., et al. Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?. Physiol Behav 92 (2007) 226-231
21. Migita K., Loewy A.D., Ramabhadran T., Krause J.E., and Waters S.M. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Res 889 (2001) 23-37
22. Molina M., Diaz J.L., Savedra M., Ortiz M., and Contreras C.M. Raphe-septal neurons changes in sensitivity to desipramine following an early septal lesion in the rat. Prog Neuropsychopharmacol Biol Psychiatry 20 (1996) 1427-1434
23. Molina M., Contreras C.M., and Téllez-Alcántara P. Antidepressant-like effects of pregnancy and progesterone in Wistar rats as measured in the differential reinforcement of the low-rate 72 s task. Psychopharmacology 151 (2000) 306-311
24. Molina M., and Téllez-Alcántara P. Estrus variation in anticonflict effects of midazolam microinjected into septal nuclei in femaleWistar rats. Pharmacol Biochem Behav 68 (2001) 531-537
25. Molina M., Téllez-Alcántara P., Perez J., Olivera J., and Jaramillo T. Anti-conflict-like actions of intra-lateral septal infusions of allopregnanolone in Wistar rats. Pharmacol Biochem Behav 75 (2003) 397-404
26. Molina M., and Téllez-Alcántara P. Rats socially-reared and full fed learned an auto-shaping task, showing less levels of fear-like behavior than fasted or singly-reared rats. Lab Anim 38 (2004) 236-245
27. Molina M., Tellez-Alcántara N.P., Pérez-García J.P., Olivera-Lopez J.I., and Jaramillo M.T. Antidepressant-like and anxiolytic-like actions of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of male Wistar rats. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1129-1135
28. Molina M., Tellez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., and Jaramillo M.T. Estrus variation in anxiolytic-like effects of intra-lateral septal infusions of the neuropeptide Y in Wistar rats in two animal models of anxiety-like behavior. Peptides 27 (2006) 2722-2730
29. Molina M., Tellez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., and Jaramillo M.T. Estrus variation in anticonflict-like effects of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of female Wistar rats. Pharmacol Biochem Behav 84 (2006) 385-391
30. National Institutes of Health. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996.
31. Obuchowicz E., Krysiak R., and Herman Z. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?. Neurosci Biobehav Rev 28 (2004) 595-610
32. Olivera J., Molina M., Tellez-Alcántara N.P., and Jaramillo T. Estradiol and neuropeptide Y (intra-lateral septal) reduce anxiety-like behavior in two animal models of anxiety. Peptides 29 (2008) 1396-1403
33. Paxinos G., and Watson C. The Rat Brain In Stereotaxic Coordinates (1982), Academic Press, New York
34. Redrobe J., Dumont Y., and Quirion R. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci 71 (2002) 2921-2937
35. Rodgers R.L., and Dalvi A. Anxiety, defense and the elevated plus-maze. Neurosci Biobehav Rev 21 (1997) 801-810
36. Sajdyk T.J., Shekhar A., and Gehlert D.R. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38 (2004) 225-234
37. Sheehan T.P., Chambers R.A., and Russel D.S. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Rev 46 (2004) 71-117
38. Stogner K., and Holmes P. Neuropeptide Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 387 (2000) R9-R10
39. Tatsuta T., Kitanaka N., Kitanaka J., Morita Y., and Takemura M. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice. Pharmacol Biochem Behav 87 (2007) 48-55
40. White S., Smith M., and Wilcox K. Mechanisms of actions of antiepileptic drugs. Int Rev Neurobiol 81 (2007) 85-110
41. Yadin E., Thomas E., Grishka H.L., and Strickland C.E. The role of the lateral septum in anxiolysis. Physiol Behav 53 (1993) 1077-1083